Eyepoint Pharmaceuticals Inc (EYPT) — Net Asset Momentum
Eyepoint Pharmaceuticals Inc (EYPT) recorded a net asset momentum of 26.4% as of December 2024, with net assets of $336.50 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Eyepoint Pharmaceuticals Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Eyepoint Pharmaceuticals Inc Net Asset Momentum (2000–2024)
This chart tracks Eyepoint Pharmaceuticals Inc's year-over-year net asset growth across 24 annual reporting periods from 2000 to 2024. The most recent momentum reading is +26.4%, with net assets of $336.50 Million USD as of December 2024. Read total liabilities of Eyepoint Pharmaceuticals Inc for a breakdown of total debt and financial obligations.
Annual Net Asset History for Eyepoint Pharmaceuticals Inc (2000–2024)
The table below shows the complete annual net asset history for Eyepoint Pharmaceuticals Inc from 2000 to 2024, covering 24 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Eyepoint Pharmaceuticals Inc market cap and net worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $336.50 Million | $418.46 Million | $81.96 Million | ▲ +26.4% |
| 2023 | $266.32 Million | $355.18 Million | $88.86 Million | ▲ +176.4% |
| 2022 | $96.37 Million | $180.36 Million | $83.99 Million | ▼ -47.7% |
| 2021 | $184.38 Million | $263.37 Million | $78.99 Million | ▲ +894.4% |
| 2020 | $18.54 Million | $91.72 Million | $73.18 Million | ▲ +122.6% |
| 2019 | $8.33 Million | $72.97 Million | $64.64 Million | ▼ -28.7% |
| 2018 | $11.69 Million | $71.67 Million | $59.98 Million | ▼ -12.4% |
| 2017 | $13.34 Million | $18.68 Million | $5.34 Million | ▼ -36.1% |
| 2016 | $20.88 Million | $31.62 Million | $10.74 Million | ▼ -10.6% |
| 2015 | $23.37 Million | $32.37 Million | $9.00 Million | ▲ +56.6% |
| 2014 | $14.92 Million | $22.67 Million | $7.75 Million | ▲ +93.8% |
| 2013 | $7.70 Million | $16.25 Million | $8.55 Million | ▼ -43.5% |
| 2012 | $13.64 Million | $20.60 Million | $6.96 Million | ▼ -63.6% |
| 2011 | $37.43 Million | $47.11 Million | $9.68 Million | ▲ +13.3% |
| 2010 | $33.04 Million | $43.01 Million | $9.97 Million | ▲ +40.4% |
| 2009 | $23.54 Million | $37.10 Million | $13.56 Million | ▲ +8.0% |
| 2008 | $21.79 Million | $39.23 Million | $17.44 Million | ▼ -66.9% |
| 2007 | $65.91 Million | $86.12 Million | $20.21 Million | ▼ -0.4% |
| 2006 | $66.20 Million | $97.60 Million | $31.40 Million | ▲ +9.0% |
| 2005 | $60.74 Million | $62.30 Million | $1.56 Million | ▲ +0.0% |
| 2004 | $60.74 Million | $62.30 Million | $1.56 Million | ▲ +127.5% |
| 2003 | $26.70 Million | $28.05 Million | $1.35 Million | ▲ +531.0% |
| 2002 | $4.23 Million | $4.82 Million | $588.38K | ▼ -7.5% |
| 2000 | $4.57 Million | $4.72 Million | $145.74K | — |